Effects of α-tocopherol on oxidative status and metabolic profile in overweight women

International Journal of Environmental Research and Public Health

Volumn 4, Issue 4, 2007, Pages 260-267

  Ble Castillo, J L ^a,b   Cleva Villanueva, G ^c   Diaz Zagoya J C ^b,d   Medina Santillan R ^c   Rubio Arias, H O ^e   Mendez J D ^f  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

^f HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Lipid peroxidation; Overweight; Oxidative stress; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MAGNESIUM; MALONALDEHYDE; PHOSPHATE; RETINOL; SELENIUM; TRIACYLGLYCEROL LIPASE; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GASTROINTESTINAL DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; LIPID PEROXIDATION; METABOLISM; NORMAL HUMAN; OBESITY; OXIDATIVE STRESS; PATIENT COMPLIANCE;

EID: 38149079786     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph200704040001     Document Type: Article

References (45)

1. González-Correa, J. A.; Arrebola, M. M.; Guerrero, A.; Cañada, M. J.; Muñoz-Marín, J.; Sánchez de la Cuesta, F.; De la Cruz, J. P.: Antioxidant and antiplatelet effects of the alpha-tocopherol-aspirin combination in type 1-like diabetic rats. Life Sciences, 2006, 79, 1405-1412.
2. Mustacich, D. J.; Leonard, S. W.; Devereaux, M. W.; Sokol, R. J.; Traber, M. G.: α-tocopherol regulation oh hepatic cytochrome P450s and ABC transporters in rats. Free Rad Biol Med, 2006, 41, 1069-1078.
3. Brown, K. M.; Morrice, P. C.; Duthie, G. G.: Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers. Dose response to vitamin E supplementation. Am J Clin Nutr, 1997, 65, 496-502.
4. Winterbone, M. S.; Sampson, M. J.; Saha, S.; Hughes, J. C.; Hughes, D. A.: Pro-oxidant effect of α-tocopherol in patients with Type 2 Diabetes after an oral glucose tolerance test-a randomized controlled trial. Cardiovasc Diabetol, 2007, 6:8.
5. Hatchcock, J. N.; Azzi, A.; Blumberg, J.; Bray, T.; Dickinson, A.; Frei, B.; Jialal, I.; Johnston, C. S.; Kelly, F. J.; Kraemer, K.; Packer, L.: Vitamin E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005, 81, 736-45.
6. Bjelakovic, G.; Nikolova, D.; Simonetti, R. G.; Gluud, C.: Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet, 2004, 364, 1219-1228.
7. Miller, E. R.; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R. A.; Appel, L. J.; Guallar, E.: Metaanalysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med, 2005, 142, 37-46.
8. Skrha, J.; Sindelka, G.; Kvasnicka, J.; Hilgertova, J.: Insulin action and fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus. Diabetes Res Clin Pract, 1999, 44, 27-33.
9. Paolisso, G.; D'Amore, A.; Galzerano, D.; Balbi, V.; Giugliano, D.; Varricchio, M.; D'Onofrio, F.: Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care, 1993, 16, 1433-1437.
10. Jacob, S.; Ruus, P.; Hermann, R.; Tritschler, H. J.; Maerker, E.; Renn, W.; Augustin, H. J.; Dietze, G. J.; Rett, K.: Oral administration of RAC-α-lipoic acid modulates insulin sensitivity in patients with type 2 diabetes mellitus: a placebo-controlled pilot trial. Free Rad Biol Med, 1999, 27, 309-314.
11. Ford, E. S.; Mokdad, A. H.; Giles, W. H.; Brown, D. W.: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003, 52, 2346-2352.
12. Keaney, J. F. Jr, ; Larson, M. G.; Vasan, R. S.; Wilson, P. W.; Lipinska, I.; Corey, D.; Massaro, J. M.; Sutherland, P.; Vita, J. A.; Benjamin, E. J.: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol, 2003, 23, 434-439.
13. Olusi, S. O.: Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord, 2002, 26, 1159-1164.
14. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 2004, 114, 1752-1761.
15. Manning, P. J.; Sutherland, W. H. F.; Walker, R. J.; Williams, S. M.; de Jong, S. A.; Ryalls, A. R.: Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care, 2004, 27, 2166-2171.
16. McGavin, J. K.; Mann, J. I.; Skeaff, C. M.; Chisholm, A.: Comparison of a vitamin E-rich diet and supplemental vitamin E on measures of vitamin E status and lipoprotein profile. Eur J Clin Nutr, 2001, 55, 555-561.
17. National Nutrition Survey. Nutritional status of children and women in Mexico. Mexico Department of Health. Nutrition. (ENN-99). 1999. Internet: http://www.salud.gob.mx/unidades/cdi/documentos/nutrición.pdf (accessed March 10, 2006).
18. Bucolo, G.; David, H.: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973, 19, 476-482.
19. Allain, C. C.; Poon, L. S.; Chanm, C. S.; Richmond W.; Fu, P. C.: Enzymatic determination of total serum cholesterol. Clin Chem, 1974, 20, 470-475.
20. Friedewald, W. T.; Levy, R. I. Fredrickson, D. S.: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972, 18, 499-502.
21. Paglia, D. E.; Valentine, W. N.: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 1967, 70, 158-169.
22. McCord, J. M.; Fridovich, I.: Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem, 1969, 244, 6049-6055.
23. Sowell, A. L.; Huff, D. L.; Yeager, P. R.; Caudill, S. P.; Gunter, E. W.: Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene and four retinyl esters in serum, determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin Chem. 1994, 40, 411-416.
24. Wasowicz, W.; Neve, J.; Peretz, A.: Optimized steps in fluorometric determination of thiobarbituric acidreactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem, 1993, 39, 2522-2526.
25. Brigelius-Flohé, R.; Kelly, F. J.; Salonen, J. T.; Neuzil, J.; Sing, J. M.; Azzi, A.: The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr, 2002, 76, 703-716.
26. St-Onge, M. P.; Janssen, I.; Heymsfield, S. B.: Metabolic syndrome in normal-weight Americans. New definition of the metabolically obese, normal-weight individual. Diabetes Care, 2004, 27, 2222-2228.
27. McNeill, A. M.; Rosamond, W. D.; Girman, C. J.; Golden, S. H.; Schmidt, M. I.; East, H. E.; Ballantyne, C. M.; Heiss, G.: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 2005, 28, 385-390.
28. Wellen, K. E.; Hotamisligil, G. S.: Inflammation, stress, and diabetes. J Clin Invest, 2005, 115, 1111-1119.
29. Palmieri, V. O.; Grattagliano, I.; Portincasa, P.; Palasciano, G.: Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr, 2006, 136, 3022-3026.
30. Upritchard, J. E.; Schuurman, C. R.; Wiersma, A.; Tijburg, L. B.; Coolen, S. A.; Rijken, P. J.; Wiseman, S. A.; Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults. Am J Clin Nutr. 2003, 78, 985-992.
31. Sutherland, W. H. F.; Manning, P. J.; Walker, R. J.; de Jong, S. A.; Ryalls, A. R.; Bery, E. A.: Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity, 2007, 15, 386-391.
32. Meagher, E. A.; Barry, O. P.; Lawson, J. A.; Rokach, J. R.; FitzGerald, G. A.: Effects of vitamin E on lipid peroxidation in healthy persons. JAMA, 2001, 285, 1178-1182.
33. Ble-Castillo, J. L.; Carmona-Díaz, E.; Mendez, J. D.; Larios-Medina, F. J.; Medina-Santillán, R.; Cleva-Villanueva, G. G.; Diaz-Zagoya, J. C.: Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics. Biomed Pharmacother, 2005, 59, 290-295.
34. Ceriello, A.; Giugliano, D.; Quatraro, A.; Donzella, C.; Dipalo, G.; Lefebvre, P. J.: Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetes complications? Diabetes Care 1991, 14, 68-72.
35. Lonn, E.; Yusuf, S.; Hoogwerf, B.; Pogue, J.; Yi, Q.; Zinman, B., Bosch, J.; Dagenais, G.; Mann, J. F.; Gerstein, H. C.: Effects of vitamin E on cardiovascular and microvascular outcomes in highrisk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care, 2002, 25, 1919-1927.
36. Rodríguez-Morán, M.; Guerrero-Romero, F.: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. A randomized double-blind controlled trial. Diabetes Care, 2003, 26, 1147-1152.
37. McLean, R. M.: Magnesium and its therapeutic uses. Am J Med, 1994, 96, 63-76.
38. Manuel y Keenoy, B.; Moorkens, G.; Vertommen, J.; Noe, M., Nève, J.; De Leeuw, I.: Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: Effects of supplementation with magnesium. J Am Coll Nutr, 2000, 19, 374-382.
39. Paolisso, G.; Tagliamonte, M. R.; Barbieri, M.; Zito, G. A.; Gambardella, A.; Varricchio, G.; Ragno, E.; Varricchio, M.: Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in Type II diabetic patients. J Clin Endocrinol Metab, 2000, 85, 109-115.
40. Michiels, C.; Raes, M.; Toussaint, O.; Remacle, J.: Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med, 1994, 17, 235-248.
41. de Haan, J. B.; Cristiano, F.; Iannello, R.; Bladier, C.; Kelner, M. J.; Kola, I.: Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet, 1996, 5, 283-292.
42. Brown, K. M.; Morrice, P. C.; Arthur, J. R.; Duthie, G. G.: Effects of vitamin E supplementation on erythrocyte antioxidant defense mechanisms of smoking and non-smoking men. Clin Sci, 1996, 91, 107-111.
43. Chiarelli, F.; Santilli, F.; Sabatino, G.; Blasetti, A.; Tumini, S.; Cipollone, F., Mezzetti, A.; Verrotti, A.: Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. Ped Res, 2004, 56, 720-725.
44. Eder, K.; Flader, D.; Hirche, F.; Brandsch, C.: Excess dietary vitamin E lowers the activities of antioxidative enzymes in erythrocytes of rats fed salmon oil. J Nutr, 2002, 132, 3400-3404.
45. Olaiz-Fernández, G.; Rivera-Dommasco, J.; Shamah-Levy, T.; Rojas, R.; Villalpando-Hernández, S.; Hernández-Avila, M.: Encuesta Nacional de Salud y Nutrición. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.